iNtRON Biotechnology Inc (048530) - Total Liabilities

Latest as of September 2025: ₩4.73 Billion KRW ≈ $3.20 Million USD

Based on the latest financial reports, iNtRON Biotechnology Inc (048530) has total liabilities worth ₩4.73 Billion KRW (≈ $3.20 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of iNtRON Biotechnology Inc to see how much of total assets are deployed in long-term investments.

iNtRON Biotechnology Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how iNtRON Biotechnology Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see iNtRON Biotechnology Inc balance sheet assets.

iNtRON Biotechnology Inc Competitors by Total Liabilities

The table below lists competitors of iNtRON Biotechnology Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Madusari Murni Indah Tbk PT JK:MOLI	Indonesia	Rp219.97 Billion
BranchOut Food Inc. Common Stock NASDAQ:BOF	USA	$12.81 Million
HSS Engineers Bhd KLSE:0185	Malaysia	RM178.00 Million
Farmsco KO:036580	Korea	₩851.51 Billion
Nurol Gayrimenkul Yatirim Ortakligi AS IS:NUGYO	Turkey	TL394.10 Million
Noble Development Public Company Limited BK:NOBLE	Thailand	฿16.07 Billion
Thai Wacoal Public Company Limited BK:WACOAL	Thailand	฿927.57 Million
Wspierania Przedsiebiorczosci WAR:PTW	Poland	zł87.38 Million

Liability Composition Analysis (2012–2024)

This chart breaks down iNtRON Biotechnology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See iNtRON Biotechnology Inc (048530) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how iNtRON Biotechnology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for iNtRON Biotechnology Inc (2012–2024)

The table below shows the annual total liabilities of iNtRON Biotechnology Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩2.60 Billion ≈ $1.76 Million	+38.37%
2023-12-31	₩1.88 Billion ≈ $1.27 Million	-94.59%
2022-12-31	₩34.78 Billion ≈ $23.57 Million	-33.14%
2021-12-31	₩52.02 Billion ≈ $35.25 Million	+243.19%
2020-12-31	₩15.16 Billion ≈ $10.27 Million	-37.03%
2019-12-31	₩24.07 Billion ≈ $16.31 Million	+53.26%
2018-12-31	₩15.70 Billion ≈ $10.64 Million	+2.07%
2017-12-31	₩15.38 Billion ≈ $10.43 Million	+47.13%
2016-12-31	₩10.46 Billion ≈ $7.09 Million	+76.39%
2015-12-31	₩5.93 Billion ≈ $4.02 Million	-23.17%
2012-12-31	₩7.72 Billion ≈ $5.23 Million	--

About iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$60.63 Million

₩89.47 Billion KRW

Market Cap Rank

#21248 Global

#1235 in Korea

Share Price

₩2830.00

Change (1 day)

-4.07%

52-Week Range

₩2330.00 - ₩6650.00

All Time High

₩46250.00